<P>Aegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for
Current Topics in Complement II
โ Scribed by Robin MacLaren, Wei Cui, Katherine Cianflone (auth.), John D. Lambris (eds.)
- Publisher
- Springer-Verlag New York
- Year
- 2008
- Tongue
- English
- Leaves
- 347
- Series
- Advances in Experimental Medicine and Biology 632
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Complement has long been regarded as a pivotal effector arm of the innate immune response, eliciting important immunoregulatory functions in the context of inflammation and also serving as a vital link between the innate and adaptive immune response. In the post-genomic era, our knowledge of the innate immune system is enriched by findings that point to novel functions that do not strictly correlate with immunological defense and surveillance, immune modulation or Inflammation. Several studies indicate that complement proteins exert functions that are either more complex than previously thought, or go well beyond the innate immune character of the system. The advent of high-throughput platforms for genome and proteome-wide profiling, together with the enormous amount of raw genetic information that has accumulated in the databases, have stirred new expectations in biomedical research. They have led complementologists to revisit established biological systems, such as the complement system, from a global and integrative perspective. Complement research is now faced with the challenge of trying to integrate isolated biochemical pathways into complex gene and protein regulatory circuits.
In this respect, scientists from around the world convened at the Fourth Aegean Conferences Workshop on Complement Associated Diseases, Animal Models, and Therapeutics (June 10-15, 2007), to discuss recent advances in this fast evolving field. This volume represents a collection of topics on the โnovelโ functions of complement, patho-physiology, protein structures, design of complement inhibitors, and complement assays discussed during the conference.
โฆ Table of Contents
Front Matter....Pages i-xxx
Adipokines and the Immune System: An Adipocentric View....Pages 1-21
The Role of Complement in Stroke Therapy....Pages 22-32
Food Intake Regulation by Central Complement System....Pages 33-44
A Pivotal Role of Activation of Complement Cascade (CC) in Mobilization of Hematopoietic Stem/Progenitor Cells (HSPC)....Pages 45-58
Regulation of Tissue Inflammation by Thrombin-Activatable Carboxypeptidase B (or TAFI)....Pages 59-67
Interaction Between the Coagulation and Complement System....Pages 68-76
Platelet Mediated Complement Activation....Pages 77-87
Adrenergic Regulation of Complement-Induced Acute Lung Injury....Pages 88-98
Ficolins: Structure, Function and Associated Diseases....Pages 99-109
Complement Factor H: Using Atomic Resolution Structure to Illuminate Disease Mechanisms....Pages 110-135
Role of Complement in Motor Neuron Disease: Animal Models and Therapeutic Potential of Complement Inhibitors....Pages 136-151
The Role of Membrane Complement Regulatory Proteins in Cancer Immunotherapy....Pages 152-167
Role of Complement in Ethanol-Induced Liver Injury....Pages 168-179
Immune Complex-Mediated Cytokine Production is Regulated by Classical Complement Activation both In Vivo and In Vitro....Pages 180-194
Subversion of Innate Immunity by Periodontopathic Bacteria via Exploitation of Complement Receptor-3....Pages 195-211
Staphylococcal Complement Inhibitors: Biological Functions, Recognition of Complement Components, and Potential Therapeutic Implications....Pages 212-227
Human Astrovirus Coat Protein: A Novel C1 Inhibitor....Pages 228-242
Hypothesis: Combined Inhibition of Complement and CD14 as Treatment Regimen to Attenuate the Inflammatory Response....Pages 243-253
Targeting Classical Complement Pathway to Treat Complement Mediated Autoimmune Diseases....Pages 254-261
Compstatin: A Complement Inhibitor on its Way to Clinical Application....Pages 262-281
Derivatives of Human Complement Component C3 for Therapeutic Complement Depletion: A Novel Class of Therapeutic Agents....Pages 282-296
Back Matter....Pages 309-316
โฆ Subjects
Immunology; Microbiology; Infectious Diseases; Pathology
๐ SIMILAR VOLUMES
<p><P>Complement has long been regarded as a pivotal effector arm of the innate im-mune response, eliciting important immunoregulatory functions in the context of inflammation and also serving as a vital link between the innate and adaptive immune response. In the post-genomic era, our knowledge of
<p><P>Complement has long been regarded as a pivotal effector arm of the innate im-mune response, eliciting important immunoregulatory functions in the context of inflammation and also serving as a vital link between the innate and adaptive immune response. In the post-genomic era, our knowledge of
<p>Mounting evidence in the past decade indicates that innate immunity mediates functions above and beyond first-line defense against infection. It is now appreciated that innate immune mechanisms are critically involved in the development of adaptive immunity and, moreover, the regulation of divers
<p><span>Complement has long been regarded as a pivotal effector arm of the innate im-mune response, eliciting important immunoregulatory functions in the context of inflammation and also serving as a vital link between the innate and adaptive immune response. In the post-genomic era, our knowledge